Company Profile
Genmab
Company Overview
Genmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody therapeutics. For 25 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.
Company History
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific.
Notable Accomplishments / Recognition
2024 Top Employer (Top Employers Institute); 2024 Best Places to Work (NJBIZ Magazine)
Benefits
Medical, Dental, Eye / Vision, Disability, Paid Vacation, Paid Sick Leave, Pension / 401(k)
Gym reimbursement